References
- Brown HL. Opioid management in pregnancy and postpartum. Obstet Gynecol Clin North Am. 2020;47(3):1–6. doi: 10.1016/j.ogc.2020.04.005.
- Klaman SL, Isaacs K, Leopold A, et al. Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: literature review to support national guidance. J Addict Med. 2017;11(3):178–190. doi: 10.1097/ADM.0000000000000308.
- Suarez EA, Huybrechts KF, Straub L, et al. Buprenorphine versus methadone for opioid use disorder in pregnancy. N Engl J Med. 2022;387(22):2033–2044. doi: 10.1056/NEJMoa2203318.
- Committee opinion no. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017;130(2):e81–e94. doi: 10.1097/AOG.0000000000002235.
- Jones HE, O’Grady KE, Malfi D, et al. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict. 2008;17(5):372–386. doi: 10.1080/10550490802266276.
- Reddy UM, Davis JM, Ren Z, et al. Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes workshop invited speakers. Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstet Gynecol. 2017;130(1):10–28. doi: 10.1097/AOG.0000000000002054.
- Jones HE, Terplan M, Meyer M. Medically assisted withdrawal (detoxification): considering the mother-infant dyad. J Addict Med. 2017;11(2):90–92. doi: 10.1097/ADM.0000000000000289.
- Schiff DM, Nielsen T, Terplan M, et al. Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstet Gynecol. 2018;132(2):466–474. doi: 10.1097/AOG.0000000000002734.